1105 / 1816
Molecular subtypes, residual disease
and 5-yr LRR
Median follow up 62 months
5-yr LRR 8% overall cohort
pCR
vs
no pCR: 0% vs 9%, p=0.05
Endpoint LRR: HR (TN) 4.4, p=0.003 and HR (ypN+) 9.8, p=0.03
All patients, n=233
Patients with no pCR, n=201
5-yr LRR
p
5-yr LRR
p
TN
20%
0.005
26%
<0.001
HER2+
6%
7%
HR+
4%
4%